CorrectSequence Therapeutics
Suzhou, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A gene therapy pioneer using CRISPR to develop curative treatments for genetic disorders.
Genetics & Genomics
Technology Platform
A gene editing platform utilizing CRISPR-based technologies to precisely correct disease-causing mutations in the genome.
Opportunities
Potential to create definitive, one-time cures for debilitating genetic diseases that currently have no effective treatments.
Risk Factors
Substantial risks related to off-target editing effects, immune responses, long-term safety, and challenging clinical development pathways.
Competitive Landscape
Competes in the high-stakes global gene editing field, requiring differentiation in editing efficiency, delivery, and intellectual property.